{
    "url_original": "https://www.wsj.com/articles/cdc-advisory-panel-considers-pfizer-covid-19-boosters-for-12-to-15-year-olds-11641378601?mod=business_lead_pos2",
    "url": "cdc-advisory-panel-considers-pfizer-covid-19-boosters-for-12-to-15-year-olds-11641378601",
    "title": "CDC Advisory Panel Considers Pfizer Covid-19 Boosters for 12- to 15-Year-Olds",
    "sub_head": "The adolescents could gain access to the shots for the first time if the panel and CDC sign off",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2022-01-05 05:30:00",
    "body": "Vaccine experts advising the Centers for Disease Control and Prevention are scheduled on Wednesday to consider whether adolescents 12 to 15 years old should gain access to Covid-19 boosters for the first time.<br />The experts’ endorsement would be one of the final steps before doctor’s offices, schools and other vaccination sites make booster shots from  Pfizer Inc.  and partner  BioNTech SE  available to 12- to 15-year-olds."
}